This mysterious lung disease affects millions of people - but a drug tested in mice shows promise
Nature • • health
Key Points:
- Researchers have identified a genetic link between the lung microbiome and idiopathic pulmonary fibrosis (IPF), a life-threatening lung disease characterized by scarring and difficulty breathing.
- Mice with a mutation in the toll-like receptor 5 (Tlr5) gene, which normally helps recognize bacteria and trigger immune responses, are more susceptible to IPF due to impaired receptor function.
- The study reveals that TLR5 receptors in airway cells help prevent harmful bacterial overgrowth following lung injury, suggesting that disruptions in this pathway contribute to IPF development.
- Current treatments for IPF only slow disease progression without improving symptoms, but targeting the TLR5 protein with drugs could offer a novel therapeutic approach to prevent disease advancement.
- Experts highlight the significance of this discovery as it opens new avenues for understanding IPF by linking genetic factors, lung microbiome interactions, and disease mechanisms.